Literature DB >> 6339627

Immunologically specific direct T lymphocyte-mediated killing of Nocardia asteroides.

R L Deem, F A Doughty, B L Beaman.   

Abstract

Macrophage-depleted populations of splenic lymphocytes obtained from immunized and nonimmunized BALB/c mice were tested to determine their ability to kill Nocardia asteroides GUH-2 in vitro. Nocardia-primed lymphocytes, but not normal lymphocytes, killed N. asteroides. The ability of these lymphocytes to kill N. asteroides could be further enhanced by in vitro activation of the lymphocytes with nocardial cell wall fragments 12 to 48 hr before challenge. The nocardicidal activity of the lymphocytes was greater in populations enriched in T cells and was eliminated by lysing the lymphocytes with anti-Thy-1.2 plus C. N. asteroides-primed T cells were unable to kill a distantly related actinomycete, Rothia dentocariosa, and killed other species of Nocardia (N. brasiliensis and N. caviae) poorly or not at all, indicating that the microbicidal activity was immunologically specific. Light microscopy and electron microscopy revealed a close association between the T cell membrane and the cell wall of N. asteroides, with possible damage to the latter structure. The ability of immunologically specific T cells to recognize, bind, and kill Nocardia may be an important mechanism of host defense, because these microorganisms often are able to escape intracellular killing by macrophages.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6339627

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  10 in total

1.  Streptococcus uberis-specific T cells are present in mammary gland secretions of cows and can be activated to kill S. uberis.

Authors:  Michel Denis; S Jane Lacy-Hulbert; Bryce M Buddle; John H Williamson; D Neil Wedlock
Journal:  Vet Res Commun       Date:  2011-02-01       Impact factor: 2.459

2.  Effect of presensitization of Nocardia asteroides with specific antibody on the viability of the organism.

Authors:  O U Osoagbaka
Journal:  World J Microbiol Biotechnol       Date:  1996-11       Impact factor: 3.312

Review 3.  Nocardia in naturally acquired and experimental infections in animals.

Authors:  B L Beaman; A M Sugar
Journal:  J Hyg (Lond)       Date:  1983-12

4.  Effect of intravenous silica on the course of Nocardia asteroides pneumonia.

Authors:  C Pomeroy; G A Filice
Journal:  Infect Immun       Date:  1988-09       Impact factor: 3.441

5.  Cytokine production and lymphocyte proliferation in patients with Nocardia brasiliensis actinomycetoma.

Authors:  Luis J Méndez-Tovar; Rafael Mondragón-González; Francisco Vega-López; Hazel M Dockrell; Roderick Hay; Rubén López-Martínez; Patricia Manzano-Gayosso; Francisca Hernández-Hernández; Carmen Padilla-Desgarennes; Alexandro Bonifaz
Journal:  Mycopathologia       Date:  2004-11       Impact factor: 2.574

6.  Impaired bactericidal activity and host resistance to Listeria monocytogenes and Borrelia burgdorferi in rats administered an acute oral regimen of ethanol.

Authors:  Charles S Pavia; Cynthia M Harris; Marie Kavanagh
Journal:  Clin Diagn Lab Immunol       Date:  2002-03

7.  Differential activity of innate defense antimicrobial peptides against Nocardia species.

Authors:  Siegbert Rieg; Benjamin Meier; Eva Fähnrich; Anja Huth; Dirk Wagner; Winfried V Kern; Hubert Kalbacher
Journal:  BMC Microbiol       Date:  2010-02-23       Impact factor: 3.605

Review 8.  Nocardia species: host-parasite relationships.

Authors:  B L Beaman; L Beaman
Journal:  Clin Microbiol Rev       Date:  1994-04       Impact factor: 26.132

Review 9.  Nocardiosis of the central nervous system: experience from a general hospital and review of 84 cases from the literature.

Authors:  Theodora Anagnostou; Marios Arvanitis; Themistoklis K Kourkoumpetis; Athanasios Desalermos; Herman A Carneiro; Eleftherios Mylonakis
Journal:  Medicine (Baltimore)       Date:  2014-01       Impact factor: 1.889

10.  Manifestations and outcomes of nocardia infections: Comparison of immunocompromised and nonimmunocompromised adult patients.

Authors:  Julie Steinbrink; Joan Leavens; Carol A Kauffman; Marisa H Miceli
Journal:  Medicine (Baltimore)       Date:  2018-10       Impact factor: 1.817

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.